Ayala Pharmaceuticals, Inc.
Disclosed SEC business address
9 DEER PARK DRIVE, SUITE K-1, MONMOUTH JUNCTION, NJ, 08852
Ayala Pharmaceuticals, Inc. (ticker CIK0001100397, CIK 0001100397) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 0 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-24T06:31:05.381252+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T09:44:23.706374+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T09:44:27.635977+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T09:44:31.749900+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.